Biotechnological advances over the last century have enabled exponential progress in the life sciences (LS) industry. Last year marked the 50th anniversary of the discovery of the double helix structure of DNA, and this year the groundbreaking CRISPR/Cas9 genome editing therapeutics are entering clinical trials for patients with genetic disorders. From personalised medicine to digitalisation and AI, progress in the life sciences industry is happening almost at lightning speed. These rapid changes have put pressure on senior management and boards to consider whether they have the right strategy and the right talent and skills in the C-suite.
Wirz & Partners has the expertise to embrace digital technologies, navigate changing regulatory landscapes and market volatility, and address health inequities.
Our expertise is in understanding your executive talent needs and the roles expected of these leaders, who face significant challenges and must find ways to differentiate themselves and remain competitive in this fast-paced environment. Through our retained search, we are confident in our unparalleled ability to recruit leaders and candidates for these roles. These talents will be able to adapt the right strategies and capabilities so that biotech companies can continue to deliver value to patients, healthcare providers and other stakeholders.
